A new rapid and effective chemistry space filter in recognizing a druglike database

Journal of Chemical Information and Modeling

Volumn 45, Issue 4, 2005, Pages 856-862

  Zheng, Suxin ^a   Luo, Xiaomin ^a   Chen, Gang ^a   Zhu, Weiliang ^a   Shen, Jianhua ^a   Chen, Kaixian ^a   Jiang, Hualiang ^a,b  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION; DATABASE SYSTEMS; MEDICINE; MOLECULAR DYNAMICS; REACTION KINETICS; SYNTHESIS (CHEMICAL);

COMPREHENSIVE MEDICINAL CHEMISTRY (CMC); DRUGLIKE DATABASE; MOLECULAR SATURATION; SPACE FILTERS;

DRUG PRODUCTS;

AROMATIC HYDROCARBON;

ARTICLE; CHEMISTRY; COMBINATORIAL CHEMISTRY; COMPUTER SIMULATION; DATA BASE; DRUG DESIGN; TIME;

COMBINATORIAL CHEMISTRY TECHNIQUES; COMPUTER SIMULATION; DATABASES; DRUG DESIGN; HYDROCARBONS, AROMATIC; TIME FACTORS;

EID: 23844520095     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci050031j     Document Type: Article

References (39)

1. Clark, D. E.; Pickett, S. D. Computational methods for the prediction of 'drug likeness'. Drug Discovery Today 2000, 5, 49-58.
2. Di, L.; Kerns, E. H. Profiling druglike properties in discovery research. Curr. Opin. Chem. Biol. 2003, 7, 402-408.
3. Smith, D. A.; van de Waterbeemd, H. Pharmacokinetics and metabolism in early drug discovery. Curr. Opin. Chem. Biol. 1999, 3, 373-378.
4. Walters, W. P.; Murcko, A.; Murcko, M. A. Recognizing molecules with druglike properties. Curr. Opin. Chem. Biol. 1999, 3, 384-387.
5. Walters, W. P.; Murcko, M. A. Prediction of 'drug likeness'. Adv. Drug Deliver. Rev. 2002, 54, 255-271.
6. Muegge, I. Selection criteria for druglike compounds. Med. Res. Rev. 2003, 23, 302-321.
7. Good, A. C.; Krystek, S. R.; Mason, J. S. High-throughput and virtual screening: core lead discovery technologies move towards integration. Drug Discovery Today 2000, 5, 61-69.
8. Liu, H.; Li, Y.; Song, M.; Tan, X.; Cheng, F., et al. Structure-Based Discovery of Potassium Channel Blockers from Natural Products: Virtual Screening and Electrophysiological Assay Testing. Chem. Biol. 2003, 10, 1103-1113.
9. Shen, J.; Xu, X.; Cheng, F.; Liu, H.; Luo, X. et al. Virtual Screening on Natural Products for Discovering Active Compounds and Target Information. Curr. Med. Chem. 2003, 10, 2327-2342.
10. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliver. Rev. 1997, 23, 3-25.
11. World Drug Index is available from Derwent Informatin, London, U.K. Website www.derwent.com.
12. MACCS-II Drug Data Report is available from MDL Information Systems Inc., San Leandro, CA, 94577 and contains biologically active compounds in the early stages of drug development.
13. The Available Chemicals Database was provided by MDL Information Systems, Inc., 1999.
14. Oprea, T. I. Property distribution of drug-related chemical databases. J. Comput.-Aided Mol. Des. 2000, 14, 251-264.
15. Comprehensive Medical Chemistry is available from MDL Information Systems Inc., San Leandro, CA, 94577 and contains drugs already in the market.
16. Ajay; Walters, W. P.; Murcko, M. A. Can We Learn To Distinguish between "Druglike" and "Nondruglike" Molecules? J. Med. Chem. 1998, 41, 3314-3324.
17. Sadowski, J.; Kubinyi, H. A Scoring Scheme for Discriminating between Drugs and Nondrugs. J. Med. Chem. 1998, 41, 3325-3329.
18. Frimurer, T. M.; Bywater, R.; Narum, L.; Lauritsen, L. N.; Brunak, S. Improving the Odds in Discriminating "Druglike" from "NonDruglike" Compounds. J. Chem. Inf. Comput. Sci. 2000, 40, 1315-1324.
19. SSKEYS, MDL Information Systems Inc., San leandro, CA.
20. Viswanadhan, V. N.; Ghose, A. K.; Revankar, G. R.; Robins, R. K. Atomic physicochemical parameters for three-dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J. Chem. Inf. Comput. Sci. 1989, 29, 163-172.
21. Gillet, V. J.; Willett, P.; Bradshaw, J. Identification of Biological Activity Profiles Using Substructural Analysis and Genetic Algorithms. J. Chem. Inf. Comput. Sci. 1998, 38, 165-179.
22. The SPRESI database is produced by the All-Union Institute of Scientific and Technical Information of the Academy of Science of the USSR (VINITI) in Moscow and the Central Information Processing for Chemistry (ZIC) in Berlin. This database consists of data extracted from 1000 journals and patents, books, and other sources from 1975 to 1990. SPRESI is distributed by Daylight Chemical Information Systems, Inc., Mission Viejo, CA.
23. Wagener, M.; van Geerestein, V. J. Potential Drugs and Nondrugs: Prediction and Identification of Important Structural Features. J. Chem. Inf. Comput. Sci. 2000, 40, 280-292.
24. Muegge, I.; Heald, S. L.; Brittelli, D. Simple Selection Criteria for Druglike Chemical Matter. J. Med. Chem. 2001, 44, 1841-1846.
25. Chinese Natural Product Database is available from the Shanghai Institute of Material Medica and contains the Chinese natural compounds published.
26. Nisbet, L. J.; Moore, M. Will natural products remain an important source of drug research for the future? Curr. Opin. Biotech. 1997, 8, 708-712.
27. Henkel, T.; Brunne, R. M.; Müller, H.; Reichel, F. Statistical Investigation into the Structural Complementarity of Natural Products and Synthetic Compounds. Angew. Chem., Int. Ed. 1999, 38, 643-647.
28. Jiang, H.; Luo, X.; Bai, D. Progress in Clinical, Pharmacological, Chemical and Structural Biological Studies of Huperzine A: A Drug of Traditional Chinese Medicine Origin for Treatment of Alzheimer' s Disease. Curr. Med. Chem. 2003, 10, 2231-2252.
29. Li, Y.; Wu, Y. An over four millennium story behind qinghaosu (artemisinin)- -a fantastic antimalarial drug from a traditional Chinese herb. Curr. Med. Chem. 2003, 10, 2197-2230.
30. Bemis, G. W.; Murcko, M. A. The Properties of Known Drugs. 1. Molecular Frameworks. J. Med. Chem. 1996, 39, 2887-2893.
31. Wang, J.; Ramnarayan, K. Toward Designing Druglike Libraries: A Novel Computational Approach for Prediction of Drug Feasibility of Compounds. J. Comb. Chem. 1999, 1, 524-533.
32. DOCK 4.0. Molecular Design Institute, San Francisco, CA, U.S.A.
33. Xu, J.; Stevenson, J. Druglike Index: A New Approach To Measure Druglike Compounds and Their Diversity. J. Chem. Inf. Comput. Sci. 2000, 40, 1177-1187.
34. Lee, M. L.; Schneider, G. Scaffold Architecture and Pharmacophoric Properties of Natural Products and Trade Drugs: Application in the Design of Natural Product-Based Combinatorial Libraries. J. Comb. Chem. 2001, 3, 284-289.
35. Feher, M.; Schmidt, J. M. Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry. J. Chem. Inf. Comput. Sci. 2003, 43, 218-227.
36. Oprea, T. I.; Davis, A. M.; Teague, S. J.; Leeson, P. D. Is There a Difference between Leads and Drugs? A Historical Perspective. J. Chem. Inf. Comput. Sci. 2001, 41, 1308-1315.
37. Nielsen, J. Combinatorial synthesis of natural products. Curr. Opin. Chem. Biol. 2002, 6, 297-305.
38. Cragg, G. M.; Newman, D. J.; Snader, K. M. Natural products in drug discovery and development. J. Nat. Prod. 1997, 60, 52-60.
39. Newman, D. J.; Cragg, G. M.; Snader, K. M. The influence of natural products upon drug discovery. Nat. Prod. Rep. 2000, 17, 215-234.